Monoclonal antibodies for treatment of cancer

Details for Australian Patent Application No. 2009294896 (hide)

Owner Ganymed Pharmaceuticals AG Johannes Gutenberg-Universitat Mainz

Inventors Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Mitnacht-Kraus, Rita

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009294896

PCT Pub. Number WO2010/031551

Priority 61/097,453 16.09.08 US; 08016277.9 16.09.08 EP

Filing date 16 September 2009

Wipo publication date 25 March 2010

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

3 March 2011 PCT application entered the National Phase

  PCT publication WO2010/031551 Priority application(s): WO2010/031551

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009294909-Elastic joint body

2009294877-Peptidomimetic macrocycles